Articles

A retrospective analysis based on outpatient data from across Ontario, showed that the risk of dying or being hospitalized with heart failure, but not of MI, is lower among older diabetic patients taking pioglitazone (Actos, Takeda Pharmaceuticals) than in those taking rosiglitazone (Avandia, GlaxoSmithKline).

This study was done to determine whether the association observed between poor glycemic control and low HDL cholesterol in Type 2 diabetes is dependent on obesity and/or hypertriglyceridemia.

A vaccine to prevent heart attacks could transform the treatment of heart disease. The new vaccine works by reversing the narrowing of the arteries, a leading cause of heart attacks.

French researchers report, that with good graft function, islet transplantation can achieve long-term metabolic control in patients with brittle Type 1 diabetes.

The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of the risk for serious effects from Chantix and DiaBeta.

While an exercise program generally leads to improvements in metabolic function in patients with Type 2 diabetes, it only improves myocardial function when activity is at least moderate to vigorous, according to a new study.

Researchers are developing a Wearable Artificial Kidney for dialysis patients which provides continuous dialysis 24 hours a day, seven days a week. 

Having comparative studies between drugs can show which drugs are cost effective. Why pay the price for newer drugs, if the older generic drugs do the same or better?

Middle-aged people who smoke or have high blood pressure or diabetes are more likely to develop dementia later in life, a new study shows.

High levels of testosterone increases appetite for risk in women: high levels connected to choice of riskier careers.